North America Network Point-of-care Glucose Testing Market Size & Outlook
Related Markets
North America network point-of-care glucose testing market highlights
- The North America network point-of-care glucose testing market generated a revenue of USD 518.1 million in 2023.
- The market is expected to grow at a CAGR of 2.9% from 2024 to 2030.
- In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
- CareSens Expert Plus is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 518.1 million |
| Market revenue in 2030 | USD 641.1 million |
| Growth rate | 2.9% (CAGR from 2024 to 2030) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | CareSens Expert Plus |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
Other key industry trends
- In terms of revenue, North America region accounted for 38.9% of the global network point-of-care glucose testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 399.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Network Point-of-Care Glucose Testing Market Scope
Network Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Nova Biomedical | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | http://www.novabio.us |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
North America network point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 49.57% in 2023. Horizon Databook has segmented the North America network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2018 to 2030.
North America generated the highest revenue in global Point-Of-Care (nPOC) glucose diagnostics/testing market in 2019 and is expected to maintain its dominance over the forecast period. This region is home to several key market players such as Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC.
This has increased availability of glucose testing products, thereby contributing to the revenue generation. In addition, higher healthcare expenditure by governments on diabetes management is one of the factors responsible for the largest share held by the region in the global market.
Furthermore, local manufacturers are continuously evolving in terms of technological advancements and are incorporating latest technologies, such as Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMR), which is expected to drive the market growth during the forecast period.
Reasons to subscribe to North America network point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America network point-of-care glucose testing market databook
-
Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America network point-of-care glucose testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America network point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America network point-of-care glucose testing market size, by country, 2018-2030 (US$M)
North America Network Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
